Difference between revisions of "OncoMouse"
Caseorganic (Talk | contribs) |
Caseorganic (Talk | contribs) |
||
| Line 1: | Line 1: | ||
===Definition=== | ===Definition=== | ||
| − | OncoMouse is a term used to describe (a type of laboratory mouse that has been genetically modified using modifications designed by Philip Leder and Timothy A Stewart<ref>European Patent Register entry for European patent no. 0169672, under "Inventor(s)". Consulted on February 22, 2008.</ref> of Harvard University to carry a specific gene called an activated oncogene. The activated oncogene significantly increases the mouse’s susceptibility to cancer, and thus makes the mouse suitable for cancer research. The rights to the invention are owned by DuPont. "OncoMouse" is a registered trademark.<ref>Trademark: USPTO serial number 75797027</ref>) http://en.wikipedia.org/wiki/Oncomouse | + | OncoMouse is the first patented animal, and an early animal cyborg. The OncoMouse is a mouse with a pump attached to it that can administer OncoMouse is a term used to describe (a type of laboratory mouse that has been genetically modified using modifications designed by Philip Leder and Timothy A Stewart<ref>European Patent Register entry for European patent no. 0169672, under "Inventor(s)". Consulted on February 22, 2008.</ref> of Harvard University to carry a specific gene called an activated oncogene. The activated oncogene significantly increases the mouse’s susceptibility to cancer, and thus makes the mouse suitable for cancer research. The rights to the invention are owned by DuPont. "OncoMouse" is a registered trademark.<ref>Trademark: USPTO serial number 75797027</ref>) http://en.wikipedia.org/wiki/Oncomouse |
Oncomouse was engineered with a pump attached to its body in order to understand how to manage human life in long term space travel. | Oncomouse was engineered with a pump attached to its body in order to understand how to manage human life in long term space travel. | ||
| − | Klines and Cline | + | Klines and Cline had a quite Positive view on the ideas of the future of space travel |
Humans, space, drugs. Environment | Humans, space, drugs. Environment | ||
| − | To surmount the everyday conditions of reality in order to | + | To surmount the everyday conditions of reality in order to ameliorate the symptoms of everyday reality |
Simply give a link to the essay if you use the picture | Simply give a link to the essay if you use the picture | ||
| + | |||
| + | Two separate patents were issued to Harvard College covering methods for providing a cell culture from a transgenic non-human animal (U.S. Patent 5,087,571; filed Mar 22, 1988, issued Feb 11, 1992, expired Feb 11, 2009) and testing methods using transgenic mice expressing an oncogene (U.S. Patent 5,925,803; filed Sep 19, 1991, issued Jul 20, 1999, expires July 20, 2016). | ||
A Cyborg Handbook. | A Cyborg Handbook. | ||
Revision as of 17:57, 5 November 2011
Definition
OncoMouse is the first patented animal, and an early animal cyborg. The OncoMouse is a mouse with a pump attached to it that can administer OncoMouse is a term used to describe (a type of laboratory mouse that has been genetically modified using modifications designed by Philip Leder and Timothy A Stewart[1] of Harvard University to carry a specific gene called an activated oncogene. The activated oncogene significantly increases the mouse’s susceptibility to cancer, and thus makes the mouse suitable for cancer research. The rights to the invention are owned by DuPont. "OncoMouse" is a registered trademark.[2]) http://en.wikipedia.org/wiki/Oncomouse
Oncomouse was engineered with a pump attached to its body in order to understand how to manage human life in long term space travel.
Klines and Cline had a quite Positive view on the ideas of the future of space travel Humans, space, drugs. Environment To surmount the everyday conditions of reality in order to ameliorate the symptoms of everyday reality
Simply give a link to the essay if you use the picture
Two separate patents were issued to Harvard College covering methods for providing a cell culture from a transgenic non-human animal (U.S. Patent 5,087,571; filed Mar 22, 1988, issued Feb 11, 1992, expired Feb 11, 2009) and testing methods using transgenic mice expressing an oncogene (U.S. Patent 5,925,803; filed Sep 19, 1991, issued Jul 20, 1999, expires July 20, 2016).
A Cyborg Handbook.
